Tempus Announces Multi-Center Validation of AI-Enabled ECG Model for Predicting Atrial Fibrillation Risk Published in Heart Rhythm

Tempus AI, Inc. (NASDAQ: TEM), a technology company leading the adoption of AI to advance precision medicine, today announced ...

AI-ECG: A New Market For A Century-Old Test

The 12-lead ECG hasn't changed in a century. The algorithms reading it have. Three CEOs and one educator on whether doctors ...
Healio

Fully automated ECG analysis system gains FDA 510(k) clearance

We were unable to process your request. Please try again later. If you continue to have this issue please contact customerservice@slackinc.com. Automated ECG interpretation system gains FDA clearance ...

Thinking about buying a smartwatch for health tracking? Don't overlook ECG feature

ECG-enabled smartwatches can help monitor heart rhythm patterns, flag irregularities and add useful context to everyday ...
MobiHealthNews

Cardiologs raises $6.5M for AI-powered ECG analysis

Paris-based Cardiologs has raised $6.5 million to support its AI-powered algorithm for ECG analysis. The round was led by a syndicate of investors including Idinvest, ISAI, Kurma Partners, and Partech ...
Medical Xpress

AI proves better than humans at analyzing long-term ECG recordings in large international study

In patients with symptoms such as irregular heartbeats, dizziness, or fainting, or in individuals that physicians suspect may have atrial fibrillation, many days of ECGs may be required for diagnosis— ...
MobiHealthNews

FDA clears Biofourmis' software for ECG-based arrhythmia detection

The FDA has granted 510(k) clearance to Biofourmis’ RhythmAnalytics, a cloud-based software product that uses deep learning to read and interpret cardiac arrhythmias. According to a statement from the ...